Overview Request Sample Pages Request Customization Download PDF
You are viewing: India Tissue Diagnostics Market analysis
Part of: Tissue Diagnostics Market (Global)

The India Tissue Diagnostics Market was valued at $145.5 Million in 2025 and projected to reach to $259.5 Million by 2030, representing a compound annual growth rate of 12.3%. India's tissue diagnostics market is positioned for sustained growth through 2030, with the market expanding from USD 145.5 million in 2025 to USD 259.5 million by 2030.

India Tissue Diagnostics Market Trends and Insights

  • This 12.3% compound annual growth rate reflects India's strengthening healthcare infrastructure, rising cancer prevalence, and increasing adoption of advanced diagnostic technologies across pathology laboratories.
  • India's growing middle class and government initiatives to improve diagnostic accessibility are driving demand for tissue-based testing in oncology, infectious disease, and autoimmune disorder detection. The tissue diagnostics sector in India is benefiting from rising awareness among healthcare providers and patients regarding early disease detection and personalized medicine.
  • India's expanding network of diagnostic centers and pathology labs, combined with improving reimbursement policies, is accelerating market penetration.
  • By 2030, India is expected to solidify its position as a key growth market within Asia Pacific, supported by technological advancements in immunohistochemistry, molecular pathology, and digital pathology solutions tailored to India's healthcare ecosystem..

Key Market Statistics

  • CAGR (2025-2030) 12.3% CAGR
  • Market Size, 2025 ~USD 145.5 Million
  • Forecast, 2030 ~USD 259.5 Million
  • Country India

India Tissue Diagnostics Market Overview

Rapid Market Expansion :

India's tissue diagnostics market is growing at 12.3% CAGR, significantly outpacing the global rate of 10%, driven by increasing healthcare investments and diagnostic infrastructure development across tier-2 and tier-3 cities.

Rising Cancer Burden :

Growing cancer prevalence in India is accelerating demand for tissue-based diagnostic services, with pathology laboratories increasingly adopting immunohistochemistry and molecular diagnostics to improve detection and treatment outcomes.

Healthcare Infrastructure Growth :

India's strengthening healthcare ecosystem, supported by government initiatives like Ayushman Bharat and increased private sector participation, is expanding access to advanced tissue diagnostic capabilities in metropolitan and emerging markets.

Middle-Class Expansion :

India's growing middle class with rising disposable income is driving demand for preventive healthcare and advanced diagnostic services, creating significant opportunities for tissue diagnostics providers and laboratory networks.

India Tissue Diagnostics Market Dynamics

  • This trajectory is underpinned by increasing cancer incidence, government healthcare reforms, and the proliferation of diagnostic centers in underserved regions.
  • The adoption of digital pathology and AI-enabled diagnostic tools is accelerating, particularly among organized laboratory chains and hospital networks. Key growth drivers include rising awareness of early disease detection, improved reimbursement policies, and partnerships between international diagnostic companies and Indian healthcare providers.
  • However, challenges such as skilled pathologist shortages and regulatory compliance requirements may moderate growth in certain segments.
  • Overall, India represents a high-potential market for tissue diagnostics innovation and market expansion..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • India's tissue diagnostics market is projected to grow from USD 145.5 million in 2025 to USD 259.5 million by 2030, representing a 12.3% CAGR.
      • Rising cancer incidence and government healthcare initiatives are primary drivers accelerating tissue diagnostic adoption across India.
      • India's expanding diagnostic infrastructure and improving reimbursement landscape are enabling wider market penetration in tier-2 and tier-3 cities.
      • Digital pathology and molecular diagnostics are emerging as high-growth segments within India's tissue diagnostics market.

      Tissue Diagnostics Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment ANTIBODIES (Type)
      Forecast Period 2025–2030
      Growth Rate CAGR of 10% from 2025 to 2030
      Largest Segment CONSUMABLES (Product & Service)
      Market Size Base Year (Billions) ~USD 6.74 (2025)
      Revenue Forecast (Billions) ~USD 10.86 (2030)
      Segments Covered Product & Service, Type, Technology, Disease, Sample Type, End User

      India Tissue Diagnostics Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Product & Service

      • Consumables
      • Instruments
      • Services
      • Software

      By Type

      • Animal Immunohistochemistry Kits
      • Antibodies
      • Blocking Sera And Reagents
      • Chromogenic Substrates
      • Digital Pathology Scanners
      • Diluents
      • Fixation Reagent
      • H&E Stainers
      • Human Immunohistochemistry Kits
      • Ihc Stainers
      • Kits
      • Microtomes
      • Organic Solvents
      • Other Instruments
      • Other Reagents
      • Primary Antibodies
      • Probes
      • Proteolytic Enzymes
      • Reagents
      • Secondary Antibodies
      • Slide-Staining Systems
      • Special Stainers
      • Tissue-Processing Systems

      By Technology

      • Digital Pathology
      • Immunohistochemistry (Ihc)
      • In Situ Hybridization (Ish)
      • Special Staining

      By Disease

      • Breast Cancer
      • Gastric Cancer
      • Lymphoma
      • Non-Small Cell Lung Cancer
      • Other Diseases
      • Prostate Cancer

      By Sample Type

      • Breast Samples
      • Dermatology Samples
      • Gi Samples
      • Gynecological Samples
      • Lung Samples
      • Other Samples
      • Urological Samples

      By End User

      • Contract Research Organizations
      • Hospitals
      • Other End Users
      • Pharmaceutical Companies
      • Research Laboratories

      Target Audience

      • Diagnostic Equipment Manufacturers : Need India-specific market data to assess demand for tissue processing, staining, and imaging equipment, identify key laboratory customers, and develop localized product strategies for the rapidly expanding Indian pathology market.
      • Healthcare Investment Firms : Require validated market sizing and growth projections for India to evaluate investment opportunities in diagnostic chains, pathology networks, and digital pathology startups operating in this high-CAGR emerging market.
      • Pathology Laboratory Networks : Need competitive benchmarking data and market trends specific to India to optimize service offerings, plan capacity expansion, and identify acquisition targets or partnership opportunities in underserved regions.
      • Pharmaceutical & Biotech Companies : Require India tissue diagnostics insights to understand companion diagnostic adoption rates, identify clinical trial opportunities, and develop market access strategies for oncology and precision medicine products.
      • Healthcare Consultants & Advisors : Need comprehensive India market intelligence to advise clients on market entry strategies, competitive positioning, regulatory compliance, and growth opportunities in the tissue diagnostics and pathology services sector.

      Key Companies in the India Tissue Diagnostics Market

      CompanyHQOwnershipStrongest segments
      MEDIMMUNEUnited StatesPrivate CompanySynagis (palivizumab) and RSV franchise including MEDI8897,IMFINZI (durvalumab) oncology,Influenza vaccines (FluMist Quadrivalent and Trivalent T/LAIV),
      PHILIPSNetherlandsPublic CompanyDiagnosis & Treatment (Imaging and Image-Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep and Respiratory Care),Personal Health,
      CERNOSTICSUnited StatesPrivate CompanyTissueCypher Barrett’s clinical testing,Research-use and exploratory tissue analytics,Other potential or legacy pathology services,
      SIENNA CANCER DIAGNOSTICSAustraliaPrivate CompanyhTERT bladder cancer diagnostic test,Other assays, services, and R&D-related income,
      GENOMIC HEALTH INCUnited StatesPrivate CompanyOncotype DX Breast,Oncotype DX Colon,Prostate and other oncology assays,
      DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing and bioproduction solutions),Life Sciences (genomics, analytical instruments, and research tools),Diagnostics (clinical instruments, consumables, and software),
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
      MERCK KGAAGermanyPublic CompanyLife Science (tools, reagents, bioprocessing, CDMO),Healthcare (specialty pharma and biopharmaceuticals),Electronics (semiconductor and display materials, specialty gases),
      ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
      BECTON, DICKINSON AND COMPANYUnited StatesPublic CompanyMedical Essentials (syringes, needles, catheters, sharps, enteral),Connected Care (infusion, medication management, automation, informatics),BioPharma Systems (prefillable drug delivery systems),
      SYSMEX CORPORATIONJapanPublic CompanyHematology analyzers and reagents (XN-Series, XN-V, ProCyte Dx),Coagulation diagnostics,Blood gas, electrolyte, and urinalysis systems,

      MEDIMMUNE

      Medimmune is a private company founded in 1987 in the United States with 2,359 employees.

      PHILIPS

      Philips is a public company founded in 1891 in the Netherlands with 64,317 employees.

      CERNOSTICS

      Cernostics is a private company founded in 2008 in the United States.

      SIENNA CANCER DIAGNOSTICS

      Sienna Cancer Diagnostics is a private company founded in 2002 in Australia.

      GENOMIC HEALTH INC

      Genomic Health Inc is a private company founded in 2000 in the United States with 829 employees.

      DANAHER CORPORATION

      Danaher Corporation is a public company founded in 1969 in the United States with 59,000 employees.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a public company founded in 1999 in the United States with 18,000 employees.

      MERCK KGAA

      Merck KGaA is a public company founded in 1668 in Germany with 59,077 employees.

      ABBOTT

      Abbott is a public company founded in 1888 in the United States with 115,000 employees.

      BECTON, DICKINSON AND COMPANY

      Becton, Dickinson and Company is a public company founded in 1897 in the United States with 72,000 employees.

      SYSMEX CORPORATION

      Sysmex Corporation is a public company founded in 1968 in Japan with 10,861 employees.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise market valuation for India (USD 145.5M in 2025) and verified 12.3% CAGR projections through 2030, enabling accurate financial forecasting and investment decision-making for market entry or expansion strategies.
      • Competitive Landscape Intelligence : Understand India-specific market dynamics, key player positioning, and emerging competitors in tissue diagnostics, allowing you to identify partnership opportunities and competitive advantages in this high-growth market.
      • Regional Growth Drivers Analysis : Access detailed insights into India's unique growth catalysts including cancer prevalence trends, healthcare infrastructure development, and middle-class expansion, enabling targeted go-to-market strategies for Indian healthcare segments.
      • Regulatory & Reimbursement Insights : Gain India-specific knowledge on regulatory frameworks, government healthcare initiatives (Ayushman Bharat), and reimbursement policies affecting tissue diagnostics adoption and pricing strategies in the Indian market.
      • Investment & Expansion Planning : Leverage India market forecasts and segment analysis to identify high-potential geographic regions, laboratory networks, and hospital partnerships for capital allocation and business development initiatives through 2030.

      Frequently asked questions

      What is the current size of India's tissue diagnostics market?

      India's tissue diagnostics market was valued at USD 145.5 million in 2025 and is expected to grow to USD 259.5 million by 2030.

      What is the projected growth rate for tissue diagnostics in India?

      India's tissue diagnostics market is projected to grow at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2030.

      What factors are driving growth in India's tissue diagnostics market?

      Key drivers include rising cancer prevalence, government healthcare initiatives, expanding diagnostic infrastructure, improving reimbursement policies, and increasing adoption of advanced diagnostic technologies across India.

      Which segments are growing fastest in India's tissue diagnostics market?

      Digital pathology, molecular diagnostics, and immunohistochemistry are among the fastest-growing segments within India's tissue diagnostics market.

      How is India's tissue diagnostics market positioned within Asia Pacific?

      India is emerging as a key growth market within Asia Pacific's tissue diagnostics sector, driven by its large population, rising healthcare spending, and expanding diagnostic capabilities.

      RESEARCH METHODOLOGY

      The study involved major activities in estimating the current market size for the global tissue diagnostics market.

      Exhaustive secondary research was done to collect information on the global tissue diagnostics market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the global tissue diagnostics market.

      Four steps involved in estimating the market size are as follows:/p>

      Secondary Research

      In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

      Primary Research

      In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry's value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

      Tissue Diagnostics Market Size, and Share

      Note 1: Others include Sales Managers, Marketing Managers, and Product Managers.

      Note 2: Companies are classified into tiers based on their total revenue. Here's the breakdown of tiers:

      Tier 1 = > USD 100 million, tier 2 = USD 10 million to USD 100 million, and tier 3 = < USD 10 million

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both the top-down and bottom-up approaches were used to estimate and validate the global tissue diagnostics market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size included the following:

      • The key players in the industry have been identified through extensive secondary research.
      • The revenues generated by leading players operating in the tissue diagnostics market have been determined through primary and secondary research.
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

      The research methodology used to estimate the market size included the following:

      Tissue Diagnostics Market : Top-Down and Bottom-Up Approach

      Tissue Diagnostics Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Tissue-based diagnostic tests are performed for screening, diagnosing, and monitoring the response of cancer patients to therapy. Tissue diagnosis refers to the examination of intact tissues obtained during a medical procedure, such as biopsies and surgeries. Tissue-based diagnostic tests are used in the treatment of breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer, and other diseases (bone cancer, cervical cancer, colon cancer, cervix cancer, gallbladder carcinoma, skin cancer, HBV, Epstein-Barr virus, hepatitis, and muscular dystrophies). These diagnostic tests are carried out to identify a medical condition in its early stage so as to establish the correct course of treatment. Tissue diagnostic tests are also carried out to determine the course of recovery and response to the treatment.

      Key Stakeholders

      • Senior Management
      • End Users
      • Finance/Procurement Department
      • R&D Department

      Report Objectives

      • To define, describe, segment, and forecast the global tissue diagnostics market by product & service, technology, disease type, end user, and region
      • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the global tissue diagnostics market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
      • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
      • To benchmark players within the global tissue diagnostics market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
      • To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region

      Customization Options:

      MarketsandMarkets offers the following customizations for this market report.

      Country Information

      • Additional country-level analysis of the global tissue diagnostics market Company profiles

      Company profiles

      • Additional five company profiles of players operating in the global tissue diagnostics market
      • Product matrix, which provides a detailed comparison of the product portfolio of each company in the global tissue diagnostics market

       

      Get the Full Tissue Diagnostics Market Report

      Full forecast, segment splits, and company analysis for all Tissue Diagnostics Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status